Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-03 Purchase |
2025-02-03 7:15 pm |
Metsera Inc. | MTSR | Burow Kristina Director 10% Owner |
2,222,222 | $18 | $39,999,996 | 8,313,680 (Indirect) |
View |
| 2024-04-02 Purchase |
2024-04-04 4:30 pm |
Boundless Bio Inc. | BOLD | Burow Kristina Director 10% Owner |
200,000 | $16 | $3,200,000 | 1,181,766 (Indirect) |
View |
| 2024-02-15 Purchase |
2024-02-20 5:37 pm |
Prime Medicine Inc. | PRME | ARCH Venture Partners X LLC ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner |
3,200,000 | $6.25 | $20,000,000 | 15,456,594 (Indirect) |
View |
| 2024-02-08 Purchase |
2024-02-12 5:43 pm |
Sana Biotechnology Inc. | SANA | CRANDELL KEITH BYBEE CLINTON Burow Kristina GILLIS STEVEN 10% Owner |
1,818,181 | $5.5 | $9,999,996 | 22,747,272 (Indirect) |
View |
| 2023-11-13 Purchase |
2023-11-15 6:55 pm |
Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner |
35,010 | $11.77 | $412,140 | 4,144,827 (Indirect Direct) |
View |
| 2023-11-08 Purchase |
2023-11-13 7:01 pm |
Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner |
140,605 | $10.98 | $1,543,563 | 4,109,817 (Indirect Direct) |
View |
| 2023-11-03 Purchase |
2023-11-07 7:00 pm |
Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner |
95,694 | $11.49 | $1,099,945 | 3,969,212 (Indirect Direct) |
View |
| 2023-09-28 Purchase |
2023-09-29 6:55 pm |
Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner |
76,511 | $13.68 | $1,046,848 | 3,873,518 (Indirect Direct) |
View |
| 2023-09-26 Purchase |
2023-09-27 8:19 pm |
Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner |
58,504 | $11.97 | $700,464 | 3,797,007 (Indirect Direct) |
View |
| 2023-09-22 Purchase |
2023-09-25 9:37 pm |
Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner |
100,740 | $11.19 | $1,127,064 | 3,738,503 (Indirect Direct) |
View |
| 2023-09-19 Purchase |
2023-09-20 06:23 am |
Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner |
1,500,000 | $17 | $25,500,000 | 3,637,763 (Indirect Direct) |
View |
| 2022-10-24 Purchase |
2022-10-26 8:01 pm |
Prime Medicine Inc. | PRME | ARCH Venture Partners X LLC ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner |
800,000 | $17 | $13,600,000 | 6,128,297 (Indirect) |
View |
| 2021-07-30 Purchase |
2021-08-03 9:06 pm |
DA32 Life Science Tech Acquisition Corp. | DALS | ARCH Venture Fund XI L.P. ARCH Venture Partners XI L.P. ARCH Venture Partners XI LLC NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner |
1,600,000 | $10 | $16,000,000 | 4,500,000 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-13 Option Award |
2025-02-18 4:30 pm |
N/A 2033-09-14 |
Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner |
75,026 | $0 | 75,026 (Direct) |
View |
| 2025-02-03 Conversion |
2025-02-03 7:15 pm |
N/A N/A |
Metsera Inc. | MTSR | Burow Kristina Director 10% Owner |
78,821,106 | $0 | 8,313,680 (Indirect) |
View |
Ownership |
2025-01-30 9:42 pm |
N/A N/A |
Metsera Inc. | MTSR | Burow Kristina Director 10% Owner |
0 | $0 | 24,743,539 (Indirect) |
View |
Ownership |
2025-01-30 4:42 pm |
N/A N/A |
Maze Therapeutics Inc. | MAZE | ARCH Venture Partners X LLC ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. NELSEN ROBERT CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner |
0 | $0 | 37,588,634 (Indirect) |
View |
| 2024-06-27 Option Award |
2024-07-01 6:19 pm |
N/A 2034-06-27 |
Scholar Rock Holding Corp | SRRK | Burow Kristina Director |
31,500 | $0 | 2,382,550 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 4:11 pm |
N/A 2034-06-12 |
Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner |
48,671 | $0 | 32,008,426 (Direct) |
View |
| 2024-06-10 Conversion |
2024-06-10 7:46 pm |
N/A N/A |
Rapport Therapeutics Inc. | RAPP | ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner |
35,652,876 | $0 | 3,728,738 (Indirect) |
View |
Ownership |
2024-06-06 7:14 pm |
N/A N/A |
Rapport Therapeutics Inc. | RAPP | ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner |
0 | $0 | 3,728,738 (Indirect) |
View |
| 2024-04-02 Conversion |
2024-04-04 4:30 pm |
N/A N/A |
Boundless Bio Inc. | BOLD | Burow Kristina Director 10% Owner |
4,851,442 | $0 | 1,181,766 (Indirect) |
View |
| 2024-03-27 Option Award |
2024-03-29 4:30 pm |
N/A 2034-03-26 |
Boundless Bio Inc. | BOLD | Burow Kristina Director 10% Owner |
26,438 | $0 | 26,438 (Direct) |
View |
Ownership |
2024-03-27 8:11 pm |
N/A N/A |
Boundless Bio Inc. | BOLD | Burow Kristina Director 10% Owner |
0 | $0 | 2,494,095 (Indirect) |
View |
| 2023-12-21 Other |
2023-12-26 5:36 pm |
N/A N/A |
Scholar Rock Holding Corp | SRRK | Burow Kristina Director |
297,245 | $0 | 2,648,295 (Indirect) |
View |
| 2023-12-08 Other |
2023-12-12 7:52 pm |
N/A N/A |
Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner |
1,893,651 | $0 | 34,275,819 (Indirect) |
View |
| 2023-09-19 Conversion |
2023-09-20 06:23 am |
N/A N/A |
Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner |
17,438,324 | $0 | 3,637,763 (Direct) |
View |
| 2023-09-14 Option Award |
2023-09-18 5:54 pm |
N/A 2033-09-13 |
Neumora Therapeutics Inc. | NMRA | Burow Kristina Director |
46,455 | $0 | 46,455 (Direct) |
View |
Ownership |
2023-09-14 8:56 pm |
N/A N/A |
Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner |
0 | $0 | 28,059,040 (Indirect) |
View |
| 2023-07-28 Other |
2023-08-10 8:27 pm |
N/A N/A |
DA32 Life Science Tech Acquisition Corp. | DALS | ARCH Venture Fund XI L.P. ARCH Venture Partners XI L.P. ARCH Venture Partners XI LLC NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner |
1,600,000 | $0 | 2,250,000 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 07:34 am |
N/A 2033-06-21 |
Scholar Rock Holding Corp | SRRK | Burow Kristina Director |
36,000 | $0 | 36,000 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-09 4:13 pm |
N/A 2033-06-07 |
Gossamer Bio Inc. | GOSS | Burow Kristina Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 5:02 pm |
N/A 2033-06-06 |
Beam Therapeutics Inc. | BEAM | Burow Kristina Director |
16,532 | $0 | 5,485,582 (Direct) |
View |
| 2022-10-24 Conversion |
2022-10-26 8:01 pm |
N/A N/A |
Prime Medicine Inc. | PRME | ARCH Venture Partners X LLC ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner |
41,344,576 | $0 | 6,128,297 (Indirect) |
View |
Ownership |
2022-10-19 8:08 pm |
N/A N/A |
Prime Medicine Inc. | PRME | ARCH Venture Partners X LLC ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner |
0 | $0 | 11,456,594 (Indirect) |
View |
| 2022-09-01 Option Award |
2022-09-02 4:06 pm |
N/A 2032-09-01 |
Beam Therapeutics Inc. | BEAM | Burow Kristina Director |
10,391 | $0 | 10,391 (Direct) |
View |
| 2022-06-09 Option Award |
2022-07-15 5:21 pm |
N/A 2032-06-08 |
Gossamer Bio Inc. | GOSS | Burow Kristina Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-27 4:32 pm |
N/A 2032-05-26 |
Scholar Rock Holding Corp | SRRK | Burow Kristina Director |
28,000 | $0 | 28,000 (Direct) |
View |
| 2021-08-05 Other |
2021-08-09 8:31 pm |
N/A N/A |
DA32 Life Science Tech Acquisition Corp. | DALS | ARCH Venture Fund XI L.P. ARCH Venture Partners XI L.P. ARCH Venture Partners XI LLC NELSEN ROBERT Burow Kristina GILLIS STEVEN Member of 10% owner group 10% Owner |
701,250 | $0 | 4,465,000 (Indirect) |
View |
| 2021-07-30 Other |
2021-08-03 9:06 pm |
N/A N/A |
DA32 Life Science Tech Acquisition Corp. | DALS | ARCH Venture Fund XI L.P. ARCH Venture Partners XI L.P. ARCH Venture Partners XI LLC NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner |
650,000 | $10 | 4,500,000 (Indirect) |
View |
Ownership |
2021-07-27 9:58 pm |
N/A N/A |
DA32 Life Science Tech Acquisition Corp. | DALS | ARCH Venture Fund XI L.P. ARCH Venture Partners XI L.P. ARCH Venture Partners XI LLC NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner |
0 | $0 | 5,166,250 (Indirect) |
View |
| 2021-07-20 Conversion |
2021-07-20 8:53 pm |
N/A N/A |
Erasca Inc. | ERAS | ARCH Venture Partners X LLC ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. NELSEN ROBERT CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner |
18,794,443 | $0 | 5,527,777 (Indirect) |
View |
Ownership |
2021-07-15 9:06 pm |
N/A N/A |
Erasca Inc. | ERAS | ARCH Venture Partners X LLC ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. NELSEN ROBERT CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner |
0 | $0 | 11,055,554 (Indirect) |
View |
| 2021-06-30 Other |
2021-07-02 5:20 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Burow Kristina Director |
202,011 | $0 | 3,335,597 (Indirect) |
View |
| 2021-06-25 Other |
2021-06-29 5:20 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Burow Kristina Director |
404,022 | $0 | 3,935,597 (Indirect) |
View |